AUS
NZ
UK
CA
USA
IND
Healthcare
How Did GSK and Defensive Names Boost the FTSE 100 Amid US Data Shock?
April 30, 2025 04:44 PM BST| By Team Kalkine MediaHow Did GSK and Defensive Names Boost the FTSE 100 Amid US Data Shock?
How Did Smith & Nephew Lead Today’s Market Advance?
April 30, 2025 02:24 PM BST| By Team Kalkine MediaHow Did Smith & Nephew Lead Today’s Market Advance?
How Did GSK’s Specialty Medicines Fuel Its Profit Growth?
April 30, 2025 02:16 PM BST| By Team Kalkine MediaHow Did GSK’s Specialty Medicines Fuel Its Profit Growth?
Could Cizzle’s CIZ1B Deal Transform Lung Cancer Screening?
April 28, 2025 10:30 AM BST| By Team Kalkine MediaCould Cizzle’s CIZ1B Deal Transform Lung Cancer Screening?
Could NHS Reforms Reshape Clinical Infrastructure Contracts?
April 28, 2025 09:30 AM BST| By Team Kalkine MediaCould NHS Reforms Reshape Clinical Infrastructure Contracts?
Can Arecor’s AT278 and Arestat Platforms Transform Diabetes Care?
April 28, 2025 08:31 AM BST| By Team Kalkine MediaCan Arecor’s AT278 and Arestat Platforms Transform Diabetes Care?
Can ANGLE’s Blood Test Transform HER2 Detection?
April 28, 2025 08:31 AM BST| By Team Kalkine MediaCan ANGLE’s Blood Test Transform HER2 Detection?
Is GSK’s Vaccine Franchise Under Pressure from U.S. Policy?
April 25, 2025 03:30 PM BST| By Team Kalkine MediaIs GSK’s Vaccine Franchise Under Pressure from U.S. Policy?
Could ACCRUFeR Transform Iron Deficiency Treatment in Japan?
April 22, 2025 02:31 PM BST| By Team Kalkine MediaCould ACCRUFeR Transform Iron Deficiency Treatment in Japan?
Could Savolitinib Trial Enrollment Spark Stock Momentum?
April 22, 2025 01:30 PM BST| By Team Kalkine MediaCould Savolitinib Trial Enrollment Spark Stock Momentum?
Could Arecor’s Ultra‑Concentrated Insulin Revolutionize Diabetes Care?
April 22, 2025 12:30 PM BST| By Team Kalkine MediaCould Arecor’s Ultra‑Concentrated Insulin Revolutionize Diabetes Care?
Could Savolitinib’s Mid‑Stage Milestone Shift Oncology Prospects?
April 22, 2025 11:30 AM BST| By Team Kalkine MediaCould Savolitinib’s Mid‑Stage Milestone Shift Oncology Prospects?
Could a Novel Therapy Transform Metastatic Breast Cancer Treatment?
April 22, 2025 09:30 AM BST| By Team Kalkine MediaCould a Novel Therapy Transform Metastatic Breast Cancer Treatment?
Could Arecor’s Ultra‑Concentrated Insulin Redefine Diabetes Management?
April 22, 2025 09:30 AM BST| By Team Kalkine MediaCould Arecor’s Ultra‑Concentrated Insulin Redefine Diabetes Management?
How Is AI Enhancing Genflow Biosciences’ Gene Therapy Research?
April 21, 2025 06:30 PM BST| By Team Kalkine MediaHow Is AI Enhancing Genflow Biosciences’ Gene Therapy Research?
Could Eroxon’s Expansion Fuel Futura Medical’s Growth?
April 21, 2025 11:30 AM BST| By Team Kalkine MediaCould Eroxon’s Expansion Fuel Futura Medical’s Growth?
Could NHS Partnership Accelerate Scancell’s Cancer Vaccine Trials?
April 21, 2025 09:30 AM BST| By Team Kalkine MediaCould NHS Partnership Accelerate Scancell’s Cancer Vaccine Trials?
Does Circulogene Licensing Deal Expand LungLife AI’s Lung Cancer Test Reach?
April 17, 2025 11:30 AM BST| By Team Kalkine MediaDoes Circulogene Licensing Deal Expand LungLife AI’s Lung Cancer Test Reach?
How Is IXICO Enhancing Progress in Neurodegenerative Disease Research? | FTSE Live Update
April 16, 2025 12:30 PM BST| By Team Kalkine MediaHighlights,Revenue increased significantly year-on-year, demonstrating enhanced operational efficiency.,Global expansion initiatives are supporting research partnerships in neuroscience.,A differentiated technology platform is boosting accuracy in ne...
Is Belluscura Navigating Global Tariff Pressure as FTSE Live Tracks Healthcare Tech?
April 16, 2025 10:30 AM BST| By Team Kalkine MediaHighlights,Belluscura PLC faces tariff cost increases due to updated US import duties on respiratory products from China and Hong Kong.,The company launched the X-PLOR 5, an FDA-cleared five-level portable oxygen concentrator.,Belluscura reported a r...
